Novo Integrated Sciences Inc
Change company Symbol lookup
Select an option...
NVOS Novo Integrated Sciences Inc
SCBCX Franklin Multi-Asset Conservative Growth Fund C
BUI BlackRock Utilities, Infrastructure & Power Opportunities Trust
FDEU First Trust Dynamic Europe Equity Income
DOCU DocuSign Inc
DHCAU DHC Acquisition Corp
BCH Banco de Chile
NLRCF Northern Lights Resources Corp
ABM ABM Industries Inc
LVOXW LiveVox Holding Equity Warrants Exp 18 June 2026 *W EXP 06/18/2026
Go

Health Care : Health Care Providers & Services | Small Cap Growth
Company profile

Novo Integrated Sciences, Inc. is a parent company to subsidiaries throughout North America. It owns Canadian and United States subsidiaries, which provide solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, personalized product offerings, and rehabilitative science. Its Canadian subsidiary, Novo Healthnet Limited, provides its services and products through both clinic and eldercare related operations. It has two segments: healthcare services, and product manufacturing and development. Its primary care services include physiotherapy, chiropractic care, occupational therapy, eldercare, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury, kinesiology, vestibular therapy, and others. It also provides global consulting specialized in providing value-added services for pharmaceutical, biotech, healthcare, hospital, medical, others.

Closing Price
$1.82
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
10,195
0

Company Profile

Novo Integrated Sciences, Inc. is a parent company to subsidiaries throughout North America. It owns Canadian and United States subsidiaries, which provide solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, personalized product offerings, and rehabilitative science. Its Canadian subsidiary, Novo Healthnet Limited, provides its services and products through both clinic and eldercare related operations. It has two segments: healthcare services, and product manufacturing and development. Its primary care services include physiotherapy, chiropractic care, occupational therapy, eldercare, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury, kinesiology, vestibular therapy, and others. It also provides global consulting specialized in providing value-added services for pharmaceutical, biotech, healthcare, hospital, medical, others.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
4.90x
Price/Book (MRQ)
1.18x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

June 2022
Current Month
112.3K
Previous Month
149.7K
Percent of Float
0.97%
Days to Cover
7.9241 Days

Share Information

NVOS is in a share class of common stock
Float
11.6M
Shares Outstanding
29.9M
Institutions Holding Shares
11
1.42%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Robert MattacchioneChmn.
  • Christopher M. DavidPres.
  • James ZsebokCFO
  • Joseph M. ChalilOther
  • Michael GaynorSecy.

Address

Insider Trading

During the most recent quarter, 10K shares were bought in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.